EntryPoint's strategies will be driven by scientific, systematic and quantitative techniques to investing in the global healthcare industry. We provide institutional and family office investors with a range of uniquely designed, differentiated, high-capacity public equity portfolios tailored to investors' appetite for risk, volatility and return.
The companies at the forefront of this transformation are poised to benefit from superior organic growth prospects in large, growing domestic and international markets, and provide investors with the potential for superior returns relative to traditional healthcare industry benchmarks. We plan to target the critical innovation themes with the greatest potential to impact the industry and propel this transformation.
Quantifying the True Value of Health Enterprisesdownload now